U.S. Markets close in 3 hrs 4 mins
  • S&P 500

    4,517.60
    +31.14 (+0.69%)
     
  • Dow 30

    35,432.59
    +173.98 (+0.49%)
     
  • Nasdaq

    15,127.28
    +105.47 (+0.70%)
     
  • Russell 2000

    2,281.29
    +13.45 (+0.59%)
     
  • Gold

    1,768.80
    +3.10 (+0.18%)
     
  • EUR/USD

    1.1639
    +0.0020 (+0.1746%)
     
  • 10-Yr Bond

    1.6300
    +0.0460 (+2.90%)
     
  • Vix

    15.78
    -0.53 (-3.25%)
     
  • GBP/USD

    1.3797
    +0.0070 (+0.5077%)
     
  • USD/JPY

    114.2930
    -0.0190 (-0.0166%)
     
  • BTC-USD

    62,874.52
    +1,173.07 (+1.90%)
     
  • CMC Crypto 200

    1,460.84
    -2.52 (-0.17%)
     
  • FTSE 100

    7,217.53
    +13.70 (+0.19%)
     
  • Nikkei 225

    29,215.52
    +190.06 (+0.65%)
     

SHAREHOLDER ALERT: TILE NERV OTGLY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / December 31, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Interface, Inc. (NASDAQ:TILE)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/interface-inc-loss-submission-form?prid=11895&wire=1
Lead Plaintiff Deadline: January 11, 2021
Class Period: March 2, 2018 - September 28, 2020

Allegations against TILE include that: (i) Interface had inadequate disclosure controls and procedures and internal control over financial reporting; (ii) consequently, Interface, inter alia, reported artificially inflated income and earnings per share ("EPS") in 2015 and 2016; (iii) Interface and certain of its employees were under investigation by the SEC with respect to the foregoing issues since at least as early as November 2017, had impeded the SEC's investigation, and downplayed the true scope of the Company's wrongdoing and liability with respect to the SEC investigation; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Minerva Neurosciences, Inc. (NASDAQ:NERV)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/minerva-neurosciences-inc-loss-submission-form?prid=11895&wire=1
Lead Plaintiff Deadline: February 8, 2021
Class Period: May 15, 2017 - November 30, 2020

Allegations against NERV include that: (i) the truth about the feedback received from the FDA concerning the "end-of-Phase 2" meeting; (ii) the Phase 2b study did not use the commercial formulation of roluperidone and was conducted solely outside of the United States; (iii) the failure of the Phase 3 study to meet its primary and key secondary endpoints rendered that study incapable of supporting substantial evidence of effectiveness; (iv) the Company's plan to use the combination of the Phase 2b and Phase 3 studies would be "highly unlikely" to support the submission of an NDA; (v) reliance on these two trials in the submission of an NDA would lead to "substantial review issues" because the trials were inadequate and not well-controlled; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.

CD Projekt S.A. (OTCMKT:OTGLY)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/cd-projekt-s-a-loss-submission-form?prid=11895&wire=1
Lead Plaintiff Deadline: February 22, 2021
Class Period: January 16, 2020 - December 17, 2020

Allegations against OTGLY include that: Throughout the class period, defendants were materially false and/or misleading because they misrepresented and failed to disclose the following adverse facts pertaining to the Company's business, operations and prospects, which were known to Defendants or recklessly disregarded by them. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Cyberpunk 2077 was virtually unplayable on the current-generation Xbox or Playstation systems due to an enormous number of bugs; (2) as a result, Sony would remove Cyberpunk 2077 from the Playstation store, and Sony, Microsoft and the Company would be forced to offer full refunds for the game; (3) consequently, the Company would suffer reputational and pecuniary harm; and (4) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong



View source version on accesswire.com:
https://www.accesswire.com/622855/SHAREHOLDER-ALERT-TILE-NERV-OTGLY-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines